Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Fidarestat Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113979983A reveals a high-efficiency Rh-catalyzed hydrogenation route for Fidarestat intermediates, offering superior enantioselectivity and cost reduction for pharmaceutical manufacturing.